LIVE MARKET TRACKER :   BSE SENSEX   33592.36      |    NSE NIFTY 10357.50    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Natco Pharma rises on receiving Establishment Inspection Report for Kothur facility

Natco Pharma rises on receiving Establishment Inspection Report for Kothur facility (16-Aug-2016)

Natco Pharma is currently trading at Rs 640.00, up by 6.00 points or 0.95% from its previous closing of Rs 634.00 on the BSE.

The scrip opened at Rs. 634.75 and has touched a high and low of Rs. 654.00 and Rs. 633.00 respectively. So far 31816 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 654.00 on 16-Aug-2016 and a 52 week low of Rs. 382.20 on 24-Aug-2015.

Last one week high and low of the scrip stood at Rs. 654.00 and Rs. 615.00 respectively. The current market cap of the company is Rs. 11174.15 crore.

The promoters holding in the company stood at 51.28%, while Institutions and Non-Institutions held 26.01% and 22.70% respectively.

Natco Pharma has received successful Establishment Inspection Report (EIR) during the period February 29 to March 7, 2016 from the U.S. Food and Drug Administration (USFDA) for the inspection conducted at its drug manufacturing facility in Kothur Village, Mahaboob Nagar District, India. The Kothur facility predominantly caters to regulated international markets, including USA. 

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.


Top News Today
Moody's upgrades Vedanta Resources' corporate family rating
(21-Nov-2017)

MoodyCredit rating agency, Moody's Investors Service has upgraded London-based Vedanta Resources' corporate family rating (CFR) and senior unsecured bond rating and placed a stable rating outlook for the company.The......click on news to read complete article.

Artefact Projects bags various orders worth Rs 29.26 crore
(21-Nov-2017)

Artefact Projects bags various orders worth Rs 29.26 croreArtefact Projects has secured various projects aggregating Rs 29.26 crore. The company has received orders worth Rs 17.71 crore from Ministry of Road Transport and Highways. This includes Independent Engineer......click on news to read complete article.

Yes Bank raising $400 mn through Syndicated loan transactions in Taiwan, Japan
(21-Nov-2017)

Yes Bank raising $400 mn through Syndicated loan transactions in Taiwan, JapanYes Bank is raising $400 million (mn) through two Syndicated loan transactions in Taiwan and Japan - comprising of $250 mn from Taiwanese banks and around $150 mn from Japan. Yes Bank has successfully......click on news to read complete article.

International Stock News
Asian markets trade mostly lower in early deals on Monday
(20-Nov-2017)

Asian markets trade mostly lower in early deals on MondayMost of the Asian equity benchmarks are trading in red in the early deals on Monday as investors took a cue from Wall Street last week and noted a light week ahead in the US market with a major holiday......click on news to read complete article.

US markets closed lower as investors weighed tax plan
(18-Nov-2017)

US markets closed lower as investors weighed tax planThe US markets closed lower on Friday, with the S&P 500 and the Dow logging a second straight week of losses as investors tracked the progress of the Republican tax cut plan wending its way through......click on news to read complete article.

US markets closed lower on Tuesday
(15-Nov-2017)

US markets closed lower on TuesdayThe US markets closed lower on Tuesday, with Wall Street slumping in the face of uncertainty around efforts to overhaul tax policy and a downturn in crude-oil futures. The Dow and S&P 500 finished......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.